Clinical Trial Update: US Benchmarking Clinical Study

View source ↗

Summary

Sponsor eMyosound SAS reports that the US benchmarking clinical study is currently recruiting participants for conditions including heart failure with preserved…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis
• Heart Failure with Mid-range Ejection Fraction
• Heart Failure with Preserved Ejection Fraction
• Left Ventricular Hypertrophy
• Transthyretin Amyloid Cardiomyopathy

Snippet

Sponsor: eMyosound SAS | Conditions: HFpEF - Heart Failure With Preserved Ejection Fraction, HFmrEF | Status: RECRUITING